CERT vs SRPT · rev $385.1M vs rev $1.90B
Certara Inc (CERT) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
CERT currently screens at market cap $1.86B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CERT and SRPT stock pages for the full models.
Not investment advice.